Abstract
Background: The definition of the individual's molecular profile will promote a specific and tailored therapeutic approach for each patient. This method has found application in specific drug decision-making in the oncology field, but not for cardiovascular pathologies.
Objective: In this review, we describe some relevant molecular features of the cardiovascular disease in the context of personalized medicine, discussing how a multidisciplinary approach can favor its translation into daily patient management as a component of integrated care. Conclusion: Prevention of the Cardiovascular disease still lacks efficient models for personalized medicine, but the definition of the individual Metabolomics may represent a promising approach for filling this gap.Keywords: Cardiovascular diseases, genomics, metabolomics, innovation and communication technology, personalized medicine.
Current Pharmacogenomics and Personalized Medicine
Title:Tackling Cardiovascular Risk: New Evidence from Personalized Medicine
Volume: 15 Issue: 1
Author(s): Rosa Finelli, Antonietta V. Pascale, Paola Marotta, Anna Guida and Michele Ciccarelli*
Affiliation:
- Department of Medicine, Surgery and Dentistry, University of Salerno, Baronissi (Salerno),Italy
Keywords: Cardiovascular diseases, genomics, metabolomics, innovation and communication technology, personalized medicine.
Abstract: Background: The definition of the individual's molecular profile will promote a specific and tailored therapeutic approach for each patient. This method has found application in specific drug decision-making in the oncology field, but not for cardiovascular pathologies.
Objective: In this review, we describe some relevant molecular features of the cardiovascular disease in the context of personalized medicine, discussing how a multidisciplinary approach can favor its translation into daily patient management as a component of integrated care. Conclusion: Prevention of the Cardiovascular disease still lacks efficient models for personalized medicine, but the definition of the individual Metabolomics may represent a promising approach for filling this gap.Export Options
About this article
Cite this article as:
Finelli Rosa, Pascale V. Antonietta , Marotta Paola, Guida Anna and Ciccarelli Michele*, Tackling Cardiovascular Risk: New Evidence from Personalized Medicine, Current Pharmacogenomics and Personalized Medicine 2017; 15 (1) . https://dx.doi.org/10.2174/1875692115666170508152128
DOI https://dx.doi.org/10.2174/1875692115666170508152128 |
Print ISSN 1875-6921 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6913 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Recent Developments in Anti-dotes Against Anthrax
Recent Patents on Anti-Infective Drug Discovery Vaccine Therapy Update for Pregnant, Immunocompromised, and Chronic Diseases Patients
Recent Patents on Inflammation & Allergy Drug Discovery Psychosocial Risk Factors Related to Ischemic Heart Disease in Women
Current Pharmaceutical Design The Cannabinoid 2 Receptor as a Potential Therapeutic Target for Sepsis
Endocrine, Metabolic & Immune Disorders - Drug Targets Nonstandard Drugs and Feasible New Interventions for Autoimmune Hepatitis: Part II
Inflammation & Allergy - Drug Targets (Discontinued) The Endocannabinoid System in Peripheral Lymphocytes as a Mirror of Neuroinflammatory Diseases
Current Pharmaceutical Design Early-Life Stress and Psychiatric Disorders: Epidemiology, Neurobiology and Innovative Pharmacological Targets
Current Pharmaceutical Design Lycopene and Cardiovascular Diseases: An Update
Current Medicinal Chemistry Biomarkers in Silent Traumatic Brain Injury
Current Pharmaceutical Design Otitis Media: Epidemiology and Management
Infectious Disorders - Drug Targets The Involvement of PPARs in the Causes, Consequences and Mechanisms for Correction of Cardiac Lipotoxicity and Oxidative Stress
Current Molecular Pharmacology Factors Affecting Sexual Transmission of HIV-1: Current Evidence and Implications for Prevention
Current HIV Research Current and Future Applications for Stem Cell Therapies in Spine Surgery
Current Stem Cell Research & Therapy Could Resveratrol be a Useful Drug for the Treatment of Malignant Hemopathies?
Recent Patents on Anti-Cancer Drug Discovery Evaluation of Dendrimer Safety and Efficacy through Cell Line Studies
Current Drug Targets Bitropic D3 Dopamine Receptor Selective Compounds s Potential Antipsychotics
Current Pharmaceutical Design The Role of Hypoxia and Platelets in Air Travel-Related Venous Thromboembolism
Current Pharmaceutical Design Synthetic Approaches to the 2006 New Drugs
Mini-Reviews in Medicinal Chemistry From Surface to Nuclear Receptors: The Endocannabinoid Family Extends its Assets
Current Medicinal Chemistry Altered Mesolimbic Dopamine System in THC Dependence
Current Neuropharmacology